Business Description
HUTCHMED (China) Ltd
ISIN : US44842L1035
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.29 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 1.28 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.01 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 46.4 | |||||
3-Year Book Growth Rate | 10.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.83 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.94 | |||||
9-Day RSI | 67.1 | |||||
14-Day RSI | 63.63 | |||||
6-1 Month Momentum % | -2.52 | |||||
12-1 Month Momentum % | 18.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.72 | |||||
Quick Ratio | 2.6 | |||||
Cash Ratio | 2.2 | |||||
Days Inventory | 51.57 | |||||
Days Sales Outstanding | 49.68 | |||||
Days Payable | 52.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.5 | |||||
Shareholder Yield % | -1.43 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.13 | |||||
Operating Margin % | 2.22 | |||||
Net Margin % | 12.06 | |||||
FCF Margin % | 22.34 | |||||
ROE % | 14.13 | |||||
ROA % | 8.32 | |||||
ROIC % | 3.48 | |||||
ROC (Joel Greenblatt) % | 61.51 | |||||
ROCE % | 7.02 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.33 | |||||
PE Ratio without NRI | 33.33 | |||||
Price-to-Owner-Earnings | 19.73 | |||||
PS Ratio | 3.8 | |||||
PB Ratio | 4.29 | |||||
Price-to-Tangible-Book | 4.29 | |||||
Price-to-Free-Cash-Flow | 16.96 | |||||
Price-to-Operating-Cash-Flow | 14.43 | |||||
EV-to-EBIT | 38.99 | |||||
EV-to-Forward-EBIT | -15.54 | |||||
EV-to-EBITDA | 34.25 | |||||
EV-to-Forward-EBITDA | -12.81 | |||||
EV-to-Revenue | 2.76 | |||||
EV-to-Forward-Revenue | 3.53 | |||||
EV-to-FCF | 12.42 | |||||
Price-to-Median-PS-Value | 0.26 | |||||
Price-to-Graham-Number | 2.42 | |||||
Price-to-Net-Current-Asset-Value | 5.69 | |||||
Price-to-Net-Cash | 9.36 | |||||
Earnings Yield (Greenblatt) % | 2.56 | |||||
FCF Yield % | 5.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
HUTCHMED (China) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 771.643 | ||
EPS (TTM) (€) | 0.51 | ||
Beta | 1.19 | ||
Volatility % | 62.38 | ||
14-Day RSI | 63.63 | ||
14-Day ATR (€) | 0.47676 | ||
20-Day SMA (€) | 16.08 | ||
12-1 Month Momentum % | 18.32 | ||
52-Week Range (€) | 9.65 - 18.4 | ||
Shares Outstanding (Mil) | 170.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HUTCHMED (China) Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HUTCHMED (China) Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
HUTCHMED (China) Ltd Frequently Asked Questions
What is HUTCHMED (China) Ltd(FRA:H7T1)'s stock price today?
When is next earnings date of HUTCHMED (China) Ltd(FRA:H7T1)?
Does HUTCHMED (China) Ltd(FRA:H7T1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |